CAMBRIDGE, England--(BUSINESS WIRE)--Cantab Connect Alzheimer’s provides touchscreen iPad assessment of patients with mild to moderate Alzheimer's disease enabling drug developers to measure the cognitive im-pact of potential new drug tr